Dr Webster K. Cavenee, Ph.D
Director, Ludwig Institute for Cancer Research, San Diego
Distinguished Professor, University of California at San Diego
Dr. Cavenee’s research is directed at defining the genetic lesions in human cancer, determining their physiological significance and using such information for therapeutic approaches. His current interests include the malignant progression of astrocytic (brain) tumours, the role of DNA methylation in tumour initiation, the differentiation pathways of astrocytes and the role of fusion transcription factors in paediatric neoplasms.
Dr. Cavenee received his Ph.D. with honours in 1977 from the University of Kansas Medical School and then did postdoctoral work at the Jackson Laboratory, MIT and the University of Utah. He held faculty positions at the University of Cincinnati and McGill University. Since 1991, he has been in La Jolla where he is the Director of the Ludwig Institute for Cancer Research and Distinguished Professor at the University of California at San Diego.
Dr. Cavenee is a member of the National Academy of Sciences, a Past-President of the American Association for Cancer Research, a Fellow of the American Academy of Microbiology and a Fellow of the International Union Against Cancer. He is on the editorial boards of several journals and has served on the Board of Scientific Counsellors of the National Cancer Institute and the National Institute of Environmental Health Sciences as well as numerous advisory boards for philanthropic foundations and biotechnology companies.
His work on the genetic basis of cancer predisposition and progression comprises more than 300 publications and has been recognized with more than 80 honours and awards, most notably the Rhoads Award of the American Association for Cancer Research, the Charles S. Mott Prize of the General Motors Cancer Research Foundation and the Albert Szent Gyorgyi Award.
Click here for more information about Dr Webster Cavenee.